Clinical trial Recruiting at 1 site Observational Ages 18 and up

Evaluating neurometabolic networks for predicting survival in colorectal cancer

Official title: An Observational Study on the Prognostic Value of Neurometabolic Networks in Colorectal Cancer

Run by The First Affiliated Hospital of Zhengzhou University · NCT06930586 · Data updated 2026-11-12

This study is testing a new way to predict survival in colorectal cancer patients by looking at how different networks in the body interact and affect outcomes.

More Brain Injury trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment213 (estimated)
SponsorThe First Affiliated Hospital of Zhengzhou University
Academic / other
Locations1 site (Henan, Henan)
StatusRecruiting
StartedMarch 1, 2024
Main results expectedDecember 31, 2026
Study endsDecember 31, 2027
Registry record updatedApril 30, 2025
Trial IDNCT06930586 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are male and female patients aged 18 and older who have been diagnosed with rectal cancer.

Probably not a fit

Patients with colorectal cancer who are not eligible due to age or diagnosis may not receive any benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the prognostic value of neurometabolic networks in predicting overall survival for patients with colorectal cancer (CRC). It will evaluate the area under the curve (AUC) of a model called BRIDGE and compare its predictive capabilities against existing clinical prediction models. The study focuses on understanding the complex interactions within the gastrointestinal ecosystem and their implications for tumorigenesis and patient outcomes. By adopting a systemic perspective, the research seeks to improve early detection and management strategies for CRC.

Why it matters

Potential benefit: If successful, this study could lead to improved survival predictions for colorectal cancer patients, enabling more personalized treatment approaches.

How similar studies have gone: Other studies have shown promise in using neurometabolic networks for cancer prognosis, but this specific approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Male/Female subjects with rectal cancer of at least 18 years of age will be enrolled in this trial.

Where it's running

  • Pet/ct
    Henan, Henan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.